Budget impact of a set-dose combination of efavirenz-emtricitabine-tenofovir in the treatment of patients infected with HIV-1
Itziar Oyagüez, Miguel Casado, Manuel Cotarelo, Antonio Ramírez-Arellano, Josep Mallolas
Abstract
Open-access reader
Itziar Oyagüez, Miguel Casado, Manuel Cotarelo, Antonio Ramírez-Arellano, Josep Mallolas
Abstract
Open-access reader
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Emtricitabine, Tenofovir, Efavirenz, Human immunodeficiency virus (HIV), Medicine, Virology, Antiretroviral therapy, Viral load